首页> 外文期刊>Genes, Chromosomes and Cancer >8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes.
【24h】

8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes.

机译:具有新型t(7; 8)易位的8p11骨髓增生综合征,导致FGFR1和TIF1基因融合。

获取原文
获取原文并翻译 | 示例
       

摘要

8p11 myeloproliferative syndrome (EMS) is a clinical-pathologic entity characterized by rearrangements involving the FGFR1 gene, which encodes a receptor tyrosine kinase. These rearrangements invariably lead to aberrant fusion proteins in which the kinase activity is constitutively turned on, with resulting oncogenic properties. In this article, we describe a new translocation in EMS, t(7;8)(q34;p11), in which the FGFR1 gene is fused to a previously unidentified partner, the TIF1 gene. We show that both the TIF1-FGFR1 and FGFR1-TIF1 fusion proteins have the potential to be translated as a result of the translocation. Thus, our data extend the involvement of FGFR1 in EMS and lend support to the concept that there is a precise correlation between genotype and phenotype in this disease.
机译:8p11骨髓增生异常综合征(EMS)是临床病理实体,其特征在于涉及编码受体酪氨酸激酶的FGFR1基因重排。这些重排总是导致异常融合蛋白,其中激酶活性组成性地开启,从而导致致癌特性。在本文中,我们描述了EMS中的新易位t(7; 8)(q34; p11),其中FGFR1基因与以前未鉴定的伴侣TIF1基因融合。我们显示,TIF1-FGFR1和FGFR1-TIF1融合蛋白都有可能因移位而被翻译。因此,我们的数据扩大了FGFR1在EMS中的应用,并为该疾病的基因型和表型之间存在精确的相关性提供了支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号